IQVIA and Kexing Biopharm Expand Strategic Collaboration to Accelerate Global Biosimilar Development using AI-Enabled Capabilities

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. DFTX
6. GOOGL
7. APGE
8. MU
9. HOOD
10. IBM

Go back to IQVIA and Kexing Biopharm Expand Strategic Collaboration to Accelerate Global Biosimilar Development using AI-Enabled Capabilities
(NYSE: IQV) Delayed: 167.81 +0.04 (0.02%)
Previous Close $167.77    52 Week High $ 
Open $167.62    52 Week Low $ 
Day High $169.90    P/E N/A 
Day Low $163.35    EPS $ 
Volume 2,107,836